SurvivorNet on MSN
Colon cancer is not one disease: Why BRAF & KRAS mutations matter
Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.
A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly ...
In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...
The accelerated cellular aging and altered gene activity in early-onset colorectal cancer, when not caused by inherited ...
6hon MSN
Mom Thought Stage 4 Colorectal Cancer Was a ‘Death Sentence.’ A New Treatment Saved Her Life
A 49-year-old mom thought her symptoms were a UTI. It was stage 4 colorectal cancer that had spread to her liver. A new ...
A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors returning after surgery. This readily available and inexpensive treatment ...
Everyday Health on MSN
Colorectal cancer: Who’s really at risk?
Colorectal cancer is increasing in young adults. Risk factors include age, metabolic syndrome, lifestyle choices, family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results